Results 91 to 100 of about 41,383 (192)

The Influence of KIR Gene Polymorphisms and KIR-ligand Binding on Outcomes in Hematologic Malignancies following Haploidentical Stem Cell Transplantation: A Comprehensive Review

open access: yes, 2023
Natural killer (NK) cell behavior and function are controlled by a balance between negative or positive signals generated by an extensive array of activating and inhibiting receptors, including killer cell immunoglobulin-like receptor (KIR) proteins ...
Salmaninejad, A.   +36 more
core   +1 more source

Design and Validation of a Multiplex KIR and HLA Class I Genotyping Method Using Next Generation Sequencing

open access: yesFrontiers in Immunology, 2018
Killer cell immunoglobulin-like receptors (KIR), considered the most polymorphic natural killer (NK) cell regulators, bind HLA class-I molecules or still unknown ligands.
Laia Closa   +7 more
doaj   +1 more source

From Association to Mechanism: Regulatory Annotation and Pathway Mapping of Genes Surrounding Breast Cancer Risk Variants

open access: yesComputational and Systems Oncology, Volume 6, Issue 1, December 2026.
ABSTRACT Inherited factors account for a large share of breast cancer susceptibility, yet the biological consequences of most risk variants are still poorly understood. To address this gap, we studied 175 breast cancer risk variants confirmed by genome‐wide association studies and gathered the genes that lie near them.
Sultana Jannat   +11 more
wiley   +1 more source

Natural killer-cell KIR repertoire reconstitution after haploidentical SCT

open access: yes, 2010
We studied killer-cell Ig-like receptor (KIR)/natural killer (NK)-cell group-2-Ag repertoires on donor-derived NK cells in 28 patients after haploidentical SCT in the first 6 months after SCT and correlated results with EFS.
AVERSA, Franco   +13 more
core   +1 more source

KIR AA individuals possess strong inhibitory KIR alleles alongside HLA ligands that are protective against leukemia in the Chinese population

open access: yesFrontiers in Genetics
IntroductionThe killer-cell immunoglobulin-like receptor (KIR) gene cluster exhibits complicated diversity in haplotype content, copy-number variation (CNV), and allelic polymorphism.
Zhihui Deng   +12 more
doaj   +1 more source

Reframing Natural Killer Cell Biology for Cancer: From Cytotoxic Potential to Context‐Matched Immune States

open access: yesMedComm – Oncology, Volume 5, Issue 4, December 2026.
Natural killer (NK) cells in cancer occupy context‐dependent states shaped by exposure history, tissue adaptation, and tumor ecology. Therapeutic success requires matching NK‐cell products to dominant ecological constraints rather than relying on cytotoxicity alone.
Jinyi Dong   +4 more
wiley   +1 more source

Pendampingan dalam Pembentukan Embrio KIR pada Siswa SMAN 1 Rawalo [PDF]

open access: yes
Kelompok Karya Ilmiah Remaja (KIR) dapat ditumbuhkembangkan di lingkungan sekolah, untuk mewadahi potensi dan minat siswa di bidang ilmu pengetahuan dan teknologi.
Widyastuti, Ani   +4 more
core   +1 more source

Renin–Angiotensin System Activation Drives Early Cardiorenal Dysfunction in Normotensive Prediabetes

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
Increased angiotensin‐converting enzyme 1 (ACE1) expression in perivascular and perirenal adipose tissues of prediabetic rats contributes to early cardiovascular and cardiorenal deterioration in the absence of obesity and hypertension. Systemic Angiotensin II exacerbates the observed detrimental effects of prediabetes.
Nour‐Mounira Z. Bakkar   +6 more
wiley   +1 more source

An Integrated Forecasting and Scheduling Energy Management Framework for Renewable-Supported Grids with Aggregated Electric Vehicles

open access: yesTechnologies
The global transition towards sustainable and resilient energy systems has emphasized the need for efficient utilization of renewable energy sources (RESs) and rapid electrification of transportation.
Rania A. Ibrahim   +3 more
doaj   +1 more source

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab

open access: yesJournal for ImmunoTherapy of Cancer, 2019
Background The ECOG-ACRIN Cancer Research Group evaluated rituximab treatment schedules for patients with newly-diagnosed low-tumor-burden follicular-lymphoma (FL). All patients received 4-weekly rituximab treatments as induction therapy.
Amy K. Erbe   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy